Runfeng Chen

Aminooxyacetic acid hemihydrochloride inhibits osteoclast differentiation and bone resorption by attenuating oxidative phosphorylation

Biao-Bing Yang, KE Rong, A. Qin, 2022, Frontiers in Pharmacology.

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways

Xixi Lin, Jinmin Zhao, Zuoxing Wu, 2021, Drug design, development and therapy.

Corilagin attenuates osteoclastic osteolysis by enhancing HO‐1 and inhibiting ROS

Yuangang Su, Jiamin Liang, Qian Liu, 2022, Journal of biochemical and molecular toxicology.

Chitosan derived nitrogen-doped carbon dots suppress osteoclastic osteolysis via downregulating ROS.

Guanxiong Liu, Wenxin He, Xiankun Cao, 2020, Nanoscale.

Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signaling.

Jinmin Zhao, Jiake Xu, F. Long, 2022, International immunopharmacology.

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways

Jinmin Zhao, Jiake Xu, Zuoxing Wu, 2021, Frontiers in Pharmacology.

FRI0012 THERAPEUTIC VALUE OF CURCUMIN ON INITIATION AND DEVELOPMENT OF INFLAMMATION IN TAKAYASU’S ARTERITIS CAUSED BY HSP65-MEDIATED CCL2 OVEREXPRESSION

Lindi Jiang, Sifan Wu, Lingying Ma, 2020, Annals of the Rheumatic Diseases.